📢 Calling for #Medtech #CEOs – step into the conversation !
Between regulatory fibrillations & financing headaches, we are facing similar storms and challenges. Leading a Medtech company today means more than just keeping the heart of your company beating – it’s a combination of vision, resilience and strategy.
That’s why we’ve teamed up with Goodwin France to launch an exclusive #CEOonly morning coffee : a conversation space by and for Medtech CEOs. On the agenda :
🔹 Keynote injection from Giovanni Lauricella (Lifeblood) & Martin Gomez (Goodwin) : leadership and CEO-ship from a US perspective
🔹 Open-heart conversations, paced by our #PulseKeepers : Rémi Dangla (Stilla Technologies), David C. (RebrAIn) & Emmanuel VINCENT (Aenitis Technologies)
🗓️ May 21st 8 to 11am
📍 Paris – limited seating – registration required and subject to confirmation
📩 Want to join or suggest a CEO who should be in the room ?
#PeerLearning #Leadership #Financing #MedTechCEOs #MoneyQuest
What happens when you bring together #Medtech #CEOs, a US perspective on leadership, and honest conversations in an intimate setting?
Powerful insights from Giovanni Lauricella (Lifeblood) & Martin Gomez (Goodwin), and authentic experiences shared by our #PulseKeepers – Rémi Dangla (Stilla Technologies), David C. (RebrAIn) & Emmanuel VINCENT (Aenitis Technologies) >> our #CEOonly morning coffee sparked exactly what we hoped for: real talk, smart questions, and meaningful interactions.
Some key takeaways that resonated most :
– Things will go wrong – and sometimes, it’s simply not you. Accepting that is part of the journey
– To attract top talent in the US, your legal setup needs to be bulletproof – it’s strategic asset
– Your #2 is key – CFO, COO… its more than the tile – its the right hand !